NovAccess Global : Announces New License to Advance its Immu

NovAccess Global Announces New License to Advance its


Immunotherapy Platform


Cleveland, OH - April 30, 2024 -- NovAccess Global Inc. , a...

Related Keywords

United States , Santa Cruz Division , California , Americans , America , Dwaink Irvin , Chris Wheeler , Christopher Wheeler , Sinai Medical Center Department Of Neurosurgery , Translational Biotechnology Company , Sinai Medical Center , University Of California , World Brain Mapping Foundation , Drug Administration , Darrow Associates , Securities Exchange Commission , Department Of Chemistry Biochemistry , Novaccess Global Inc , Vaccine Manufacturing Laboratory , Securities Exchange , Novaccess Global Announces New License , Access Global , Cedars Sinai Medical Center , Novaccess Global , Orphan Drug , Chief Executive Officer , Cedars Sinai Medical Center Department , Operations Director , Precision Medicine Initiative , Brain Tumors Department , Cruz Division , Biological Sciences , Golden Axon Award , Vax Therapeutics , Cancer Stem , Investigational New Drug , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Sumner Global , Relations Contact , Markets ,